This white paper provides an insight into the advantages of autoantibodies as biomarkers and reviews the current technology trends.
Autoantibodies have been shown to offer clear advantages as diagnostic biomarkers for a range of diseases (e.g. cancer and autoimmune disease), including:
- Earlier disease detection
- Higher sensitivity and specificity
- Low assay costs
To download the full report please click on the link above.